Janux Therapeutics Inc (JANX)
54.86
+0.65
(+1.20%)
USD |
NASDAQ |
Nov 08, 12:57
Janux Therapeutics Revenue (Annual): 8.083M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 8.083M |
December 31, 2022 | 8.612M |
Date | Value |
---|---|
December 31, 2021 | 3.637M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
3.637M
Minimum
2021
8.612M
Maximum
2022
6.777M
Average
8.083M
Median
2023
Revenue (Annual) Benchmarks
Dynavax Technologies Corp | 232.28M |
Krystal Biotech Inc | 50.70M |
Arcus Biosciences Inc | 117.00M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.490M |